226 related articles for article (PubMed ID: 29988949)
1. Involvement of anti-tumor
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Yamada Y; Arai T; Kita Y; Kijima Y; Mataki Y; Maemura K; Natsugoe S
Oncotarget; 2018 Jun; 9(48):28849-28865. PubMed ID: 29988949
[TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
[TBL] [Abstract][Full Text] [Related]
3. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
5. The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the
Yonemori K; Seki N; Idichi T; Kurahara H; Osako Y; Koshizuka K; Arai T; Okato A; Kita Y; Arigami T; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Oncotarget; 2017 Sep; 8(41):70097-70115. PubMed ID: 29050264
[TBL] [Abstract][Full Text] [Related]
6. Regulation of actin-binding protein ANLN by antitumor
Idichi T; Seki N; Kurahara H; Yonemori K; Osako Y; Arai T; Okato A; Kita Y; Arigami T; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Oncotarget; 2017 Aug; 8(32):53180-53193. PubMed ID: 28881803
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of
Tanaka T; Okada R; Hozaka Y; Wada M; Moriya S; Satake S; Idichi T; Kurahara H; Ohtsuka T; Seki N
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977589
[TBL] [Abstract][Full Text] [Related]
8. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.
Koshizuka K; Hanazawa T; Kikkawa N; Arai T; Okato A; Kurozumi A; Kato M; Katada K; Okamoto Y; Seki N
Cancer Sci; 2017 Aug; 108(8):1681-1692. PubMed ID: 28612520
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of integrin β1-mediated oncogenic signalling by the antitumor
Koshizuka K; Kikkawa N; Hanazawa T; Yamada Y; Okato A; Arai T; Katada K; Okamoto Y; Seki N
Oncotarget; 2018 Jan; 9(3):3663-3676. PubMed ID: 29423074
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathogenesis and Regulation of the
Hozaka Y; Seki N; Tanaka T; Asai S; Moriya S; Idichi T; Wada M; Tanoue K; Kawasaki Y; Mataki Y; Kurahara H; Ohtsuka T
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199886
[TBL] [Abstract][Full Text] [Related]
13. MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation.
Huang W; Gu J; Tao T; Zhang J; Wang H; Fan Y
Front Oncol; 2019; 9():1499. PubMed ID: 32039003
[TBL] [Abstract][Full Text] [Related]
14. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
[TBL] [Abstract][Full Text] [Related]
17. Gene Regulation by Antitumor
Khalid M; Idichi T; Seki N; Wada M; Yamada Y; Fukuhisa H; Toda H; Kita Y; Kawasaki Y; Tanoue K; Kurahara H; Mataki Y; Maemura K; Natsugoe S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30866526
[TBL] [Abstract][Full Text] [Related]
18. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.
Wang C; Wang J; Cui W; Liu Y; Zhou H; Wang Y; Chen X; Chen X; Wang Z
Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577
[TBL] [Abstract][Full Text] [Related]
19.
Fukuda K; Seki N; Yasudome R; Mitsueda R; Asai S; Kato M; Idichi T; Kurahara H; Ohtsuka T
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239355
[TBL] [Abstract][Full Text] [Related]
20. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]